美股异动 | 阿斯利康(AZN.US)涨逾2% 高盛看多股价至99美元

智通财经
Sep 03
【美股异动 | 阿斯利康(AZN.US)涨逾2% 高盛看多股价至99美元】智通财经APP获悉,周三,阿斯利康(AZN.US)涨逾2%,报81.99美元。高盛近日发布研报称,阿斯利康此前在2025欧洲心脏病学会(ESC)年会上公布了Baxdrostat在BaxHTN III期临床试验中取得积极结果。Baxdrostat在临床试验中展现出了在治疗高血压方面的强劲效果,有望给阿斯利康带来数十亿美元的销售机会。高盛予阿斯利康“买入”评级,12个月目标价为99美元。这一目标价较该股周二收盘价80.19美元有约23%的上涨空间。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10